<?xml version="1.0" encoding="utf-8"?>
<feed xmlns="http://www.w3.org/2005/Atom">
<title>Legal Insider Trading Data | Free and Professional Subscription Services | Insider Insights</title>
<link href="http://www.insiderinsights.com/news/company/uthr" ></link>
<id>urn:uuid:dfb6340f-6ffe-dc84-0c9d-a212db4ec54e</id>
<updated>2026-05-14T08:37:43-04:00</updated>
<author>Jonathan Moreland</author>
<subtitle>Profit from legal insider trading. InsiderInsights.com provides free insider trading data tools and resources, and professional grade subscription based real time Form 4 data, analysis and services</subtitle>
<entry>
<title>UTHR: ROTHBLATT MARTINE A (CEO,DIR) Exercised 9,500 Options (OE) of UNITED THERAPEUTICS CORP for $146.03 on 5/12, and Sold Them All</title>
<link href="http://www.insiderinsights.com/company/uthr/united-therapeutics-corp/id-6401914" ></link>
<id>urn:uuid:f262abe7-79ce-a3fb-a215-d48080cc7b22</id>
<updated>2026-05-13T16:31:54-04:00</updated>
<summary type="html" ><![CDATA[UNITED THERAPEUTICS CORP (UTHR). Recent Price: $564.94. Mkt Cap:24.0B. 10D Vol: 447,450]]></summary>
</entry>
<entry>
<title>UTHR: MESA NILDA (DIR) Sold (S) 258 Shares of UNITED THERAPEUTICS CORP for $581.93 on 5/12</title>
<link href="http://www.insiderinsights.com/company/uthr/united-therapeutics-corp/id-6401894" ></link>
<id>urn:uuid:9c17a8bb-bf4b-64a5-7256-f7a6b4eefd00</id>
<updated>2026-05-13T16:31:08-04:00</updated>
<summary type="html" ><![CDATA[UNITED THERAPEUTICS CORP (UTHR). Recent Price: $564.94. Mkt Cap:24.0B. 10D Vol: 447,450]]></summary>
</entry>
<entry>
<title>UTHR: ROTHBLATT MARTINE A (CEO,DIR) Exercised 9,500 Options (OE) of UNITED THERAPEUTICS CORP for $146.03 on 5/11, and Sold Them All</title>
<link href="http://www.insiderinsights.com/company/uthr/united-therapeutics-corp/id-6401074" ></link>
<id>urn:uuid:d19b42e8-4567-5abc-7e37-69664b7c36a4</id>
<updated>2026-05-12T17:25:46-04:00</updated>
<summary type="html" ><![CDATA[UNITED THERAPEUTICS CORP (UTHR). Recent Price: $564.94. Mkt Cap:24.0B. 10D Vol: 447,450]]></summary>
</entry>
<entry>
<title>UTHR: EDGEMOND JAMES (CFO,TR) Exercised 10k Options (OE) of UNITED THERAPEUTICS CORP for $135.42 on 5/11, and Sold Them All</title>
<link href="http://www.insiderinsights.com/company/uthr/united-therapeutics-corp/id-6401068" ></link>
<id>urn:uuid:9a976afe-b668-6fe2-c64a-4c86ae4d0a42</id>
<updated>2026-05-12T17:25:06-04:00</updated>
<summary type="html" ><![CDATA[UNITED THERAPEUTICS CORP (UTHR). Recent Price: $564.94. Mkt Cap:24.0B. 10D Vol: 447,450]]></summary>
</entry>
<entry>
<title>UTHR: ROTHBLATT MARTINE A (CEO,DIR) Exercised 9,500 Options (OE) of UNITED THERAPEUTICS CORP for $146.03 on 5/8, and Sold Them All</title>
<link href="http://www.insiderinsights.com/company/uthr/united-therapeutics-corp/id-6399801" ></link>
<id>urn:uuid:3005d004-45d6-f800-c015-5a7e4eb5c637</id>
<updated>2026-05-11T16:30:32-04:00</updated>
<summary type="html" ><![CDATA[UNITED THERAPEUTICS CORP (UTHR). Recent Price: $564.94. Mkt Cap:24.0B. 10D Vol: 447,450]]></summary>
</entry>
</feed>